SDH of HPV Vaccine Completion

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

3076 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-01-07

Study Completion Date

2019-12-17

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research study is to find out which factors influence parents' ability to complete the human papillomavirus (HPV) vaccine series for their child. The information learned from this study may help the investigators develop programs to improve HPV vaccine completion rates among adolescents and reduce barriers to receiving the second shot of the vaccine series.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Study to Compare the Impact of a School Based HPV Program on Vaccination Uptake and Completion Rates

NCT01526551

Human Papillomavirus

COMPLETED NA

Facilitating Completion of HPV Vaccination

NCT01600560

Adolescent Immunizations Among Clinic Population

COMPLETED

Adolescent Vaccination in Pharmacies

NCT01960088

Evaluating Attitudes Toward HPV Vaccinations in Pharmacies Evaluating the Provision of HPV Vaccines in a Pharmacy

COMPLETED

Increasing Optimal Use of HPV Vaccination in Primary Care

NCT04180462

Human Papillomavirus Vaccines

COMPLETED NA

County Level Correlates of HPV Vaccine Series Completion Among Children Ages 11-14 Years in Indiana

NCT04576962

Human Papillomavirus Vaccination

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Human Papilloma Virus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adolescents ages 11 to 14 years

Adolescents ages 11 to 14 years who have received 1 dose of the HPV vaccine series between January 2017 and December 2017

No interventions assigned to this group

Parent of adolescents

Parents as defined as the adolescent's biological mother or father, step-parents, or legal guardian, and who self-identified as the primary caregiver of the adolescent child and most likely to make medical decisions for the adolescent.

No interventions assigned to this group

Cohort of Adolescents From Electronic Health Record (EHR)

A cohort of adolescents ages 11 to 14 who received 1 dose of the HPV vaccine from January 2017 to December 2017 within the university's health system network. The cohort was followed from January 2018 to February 2019 to assess vaccine completion within a 14-month period.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* For adolescents, participants need to be between the ages 11 to 14 years.
* Received 1 dose of the HPV vaccine series between January 2017 and December 2017.
* For parents, there is no age limit required.
* Parents as defined as the adolescent's biological mother or father, step-parents, or legal guardian.
* Parents or legal guardians who self-identified as the primary caregiver of the adolescent child and most likely to make medical decisions for the adolescent.

Exclusion Criteria

* Parents with cognitive impairment.
* Adolescents with cognitive impairment.
* Adolescents emancipated from their parents or legal guardian
* Pregnant adolescent girls.

Eligible Sex

ALL

Accepts Healthy Volunteers

No